Literature DB >> 21748181

An expedient biocatalytic procedure for abasic site precursors useful in oligonucleotide synthesis.

Saúl Martínez-Montero1, Susana Fernández, Yogesh S Sanghvi, Vicente Gotor, Miguel Ferrero.   

Abstract

Preparation of abasic site precursors through a divergent chemoenzymatic synthesis has been accomplished. Several biocatalysts and acylating agents were studied furnishing a practical and scalable green method useful for industrial applications. Highly regioselective acylation and deacylation reactions with 1,2-dideoxy-D-ribose are described resulting in excellent yield. A fast, atom-efficient and convenient synthesis of 3-, and 5-O-DMTr-1,2-dideoxyribose 17 and 19 has been achieved. These compounds are useful precursors for the preparation of phosphoramidites required for the assembly of oligonucleotides containing the tetrahydrofuran abasic lesions.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21748181     DOI: 10.1039/c1ob05739a

Source DB:  PubMed          Journal:  Org Biomol Chem        ISSN: 1477-0520            Impact factor:   3.876


  3 in total

1.  Synthesis, evaluation of anti-HIV-1 and anti-HCV activity of novel 2',3'-dideoxy-2',2'-difluoro-4'-azanucleosides.

Authors:  Saúl Martínez-Montero; Susana Fernández; Yogesh S Sanghvi; Emmanuel A Theodorakis; Mervi A Detorio; Tamara R McBrayer; Tony Whitaker; Raymond F Schinazi; Vicente Gotor; Miguel Ferrero
Journal:  Bioorg Med Chem       Date:  2012-09-23       Impact factor: 3.641

2.  Biotransformation of β-hydroxypyruvate and glycolaldehyde to l-erythrulose by Pichia pastoris strain GS115 overexpressing native transketolase.

Authors:  Yu-Chia Wei; Stephanie Braun-Galleani; Maria José Henríquez; Sahan Bandara; Darren Nesbeth
Journal:  Biotechnol Prog       Date:  2017-11-20

3.  Novel 1'-homo-N-2'-deoxy-α-nucleosides: synthesis, characterization and biological activity.

Authors:  Alejandro Carnero; Virginia Martín-Nieves; Yogesh S Sanghvi; Olivia O Russel; Leda Bassit; Raymond F Schinazi; Susana Fernández; Miguel Ferrero
Journal:  RSC Adv       Date:  2020-04-21       Impact factor: 4.036

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.